Loading…eh

🔆 📖 👤

Statutory Instruments

2022 No. 593

National Health Service, England And Wales

National Health Service, Scotland

Health And Personal Social Services, Northern Ireland

The Branded Health Service Medicines (Costs) (Amendment) Regulations 2022

Made

26th May 2022

Laid before Parliament

1st June 2022

Coming into force

1st July 2022

The Secretary of State for Health and Social Care makes the following Regulations in exercise of the powers conferred by sections 263(1)(c), 264(3), 266(1) and (4A), and 272(7) and (8) of the National Health Service Act 2006( 1 ).

The Secretary of State has consulted in accordance with sections 263(1) and (1A) of that Act.

Citation, commencement and extent

1. —(1) These Regulations may be cited as the Branded Health Service Medicines (Costs) (Amendment) Regulations 2022 and come into force on 1st July 2022.

(2) These Regulations extend to England and Wales, Scotland and Northern Ireland.

Amendment of the Branded Health Service Medicines (Costs) Regulations 2018

2. —(1) The Branded Health Service Medicines (Costs) Regulations 2018( 2 ) are amended as follows.

(2) In regulation 3 (payment scheme)

(a) in paragraph (1), for the table substitute the following table—

Table

Applicable Period Payment Percentage
1st July 2022 to the end of 2022 14.3%
2023 and any subsequent calendar year 24.4% ;

(b) in paragraph (1B)—

(i) for “1st April 2020 to the end of 2020” substitute “1st July 2022 to the end of 2022” ;

(ii) for “5.0%” substitute “17.7%” , and

(iii) for “7.4%” substitute “14.3%” ; and

(c) in paragraph (1C)—

(i) for “1st April 2020 to the end of 2020” substitute “1st July 2022 to the end of 2022” ;

(ii) in sub-paragraph (a)—

(aa) for “1st January 2020” substitute “1st January 2022” , and

(bb) for “31st March 2020” substitute “30th June 2022” , and

(iii) in sub-paragraph (b), for “14.7%” substitute “10.9%” .

Signed by the authority of the Secretary of State for Health and Social Care

Kamall

Parliamentary Under-Secretary of State,

Department of Health and Social Care

26th May 2022

( 1 )

2006 c. 41 ; section 263 was amended by the Health Service Medical Supplies (Costs) Act 2017 (c. 23) (“ the 2017 Act ”), section 5 and 10(5). Section 266 was amended by the 2017 Act, section 6(5) to (9) and 7(6). See section 275(1) of the National Health Service Act 2006 for the definition of “regulations” that are relevant to the powers being exercised.

( 2 )

S.I. 2018/345 ; relevant amending instruments are S.I. 2018/1255 and S.I. 2020/258 .

Status: This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
The Branded Health Service Medicines (Costs) (Amendment) Regulations 2022 (2022/593)
Version from: original only

Displaying information

Status of this instrument

in force Provision is in force
in force* In force only for specified purposes (see footnote)
not in force Not in force in England (may be in force in other geographies, see footnotes)
defined term Defined term
dfn Defined term (alternative style)
footnote commentary transitional and savings in force status related provisions geo extent insert/omit source count in force adj
Defined Term Section/Article ID Scope of Application

Status of changes to instrument text

The list includes made instruments, both those in force and those yet to come into force. Typically, instruments that are not yet in force (hence their changes are not incorporated into the text above) are indicated by description 'not yet' in the changes made column.

Contains public sector information licensed under the Open Government Licence v3.0.